Granules India Limited

GRANULES.NS·NSE·Healthcare
Compare
794.45−0.15 (−0.02%)today
At close: Nov 5, 3:29 PM IST · May be delayed up to 15 min · INR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close794.60
Open800.80
Day range784.90811.00
52-week range529.85923.65
Off day high−2.04%
Off 52-week high−13.99%
Volume1.23M
Avg. volume (3M)951.89K
Market cap216.71B
EPS (TTM)28.57
Forward P/E20.74
P/E ratio (TTM)27.81
Dividend yield0.22% (1.75)
Beta (5Y)0.12
Shares outstanding272.78M
Short interest—
Earnings dateJul 28, 2025 (est.)
Analyst target907.25
Profit margin11.76%

Against its peers

Compare in full ›
GRANULES.NS IPCALAB.NS IOLCP.NS RPGLIFE.NS MOREPENLAB.NS INDSWFTLAB.BO
Market cap 216.71B 494.62B 55.50B 42.93B 53.21B 31.50B
P/E (TTM) 27.8 37.8 27.3 38.7 28.3 37.0
Forward P/E 20.7 27.7 17.5 27.6 — —
Price/book 3.0 6.1 2.9 7.1 3.9 2.1
Dividend yield 0.22% 0.30% 0.54% 0.92% 0.20% —
1-year change +43.88% +51.13% +102.86% +6.05% +113.46% +268.15%
Today −0.02% −1.14% +2.89% −0.11% −4.17% −4.09%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.

Univest·Positive

Granules India Share Price Rise Streak: price, valuation

SUMMARY Granules India Ltd. Share Price Rise Streak is in its second straight session, with the latest traded price at Rs 831.55, up 2.29%, and market capitalisation at Rs 22,039.25 Cr. Granules India Ltd. (GRANULES) rose to Rs 831.55 from…

BusinessLine··2 outletsPositive

Granules India expecting sole first to file status on Ruxolitinib Extended-Release Tablets

The Hyderabad-based company has provided the required notice to the relevant parties in accordance with applicable US regulatory requirements. If confirmed by the FDA and all applicable statutory and regulatory requirements are satisfied,…

NVO
More from 1 other outlet
Urban Acres·Positive

Granules India’s ₹2,000 Crore Bet Could Reshape Hyderabad Pharma

Granules India Investment: ₹2,000 Crore Hyderabad Plan Urban Acres Granules India’s ₹2,000 Crore Bet Could Reshape Hyderabad Pharma Granules India’s plan to invest about ₹2,000 crore over the next three to four years is more than a…

From the 4Search news index, newest first.

In the news

10mentions in 30 days
10with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 10 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance